279 related articles for article (PubMed ID: 24351015)
21. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
[TBL] [Abstract][Full Text] [Related]
22. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
[TBL] [Abstract][Full Text] [Related]
23. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.
Dillon SM; Lee EJ; Bramante JM; Barker E; Wilson CC
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):259-67. PubMed ID: 24091697
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cells in HIV-1 infection and therapy.
Mikulak J; Oriolo F; Zaghi E; Di Vito C; Mavilio D
AIDS; 2017 Nov; 31(17):2317-2330. PubMed ID: 28926399
[TBL] [Abstract][Full Text] [Related]
25. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.
Alter G; Teigen N; Davis BT; Addo MM; Suscovich TJ; Waring MT; Streeck H; Johnston MN; Staller KD; Zaman MT; Yu XG; Lichterfeld M; Basgoz N; Rosenberg ES; Altfeld M
Blood; 2005 Nov; 106(10):3366-9. PubMed ID: 16002429
[TBL] [Abstract][Full Text] [Related]
26. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
27. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
29. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
[TBL] [Abstract][Full Text] [Related]
30. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
31. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
32. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
[TBL] [Abstract][Full Text] [Related]
33. Proteome analysis of human CD56
Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L
Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523
[TBL] [Abstract][Full Text] [Related]
34. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
35. Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load.
Gregson JN; Kuri-Cervantes L; Mela CM; Gazzard BG; Bower M; Goodier MR
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):84-8. PubMed ID: 22920222
[TBL] [Abstract][Full Text] [Related]
36. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
[TBL] [Abstract][Full Text] [Related]
37. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
38. Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer.
Yin M; Di G; Bian M
Int Immunopharmacol; 2018 Nov; 64():333-339. PubMed ID: 30243069
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.
Frankel TL; Burns W; Riley J; Morgan RA; Davis JL; Hanada K; Quezado M; Rosenberg SA; Royal RE
Cancer Immunol Immunother; 2010 Dec; 59(12):1757-69. PubMed ID: 20734041
[TBL] [Abstract][Full Text] [Related]
40. Delineation of multiple subpopulations of natural killer cells in rhesus macaques.
Webster RL; Johnson RP
Immunology; 2005 Jun; 115(2):206-14. PubMed ID: 15885126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
